Immunological Treatments for Autism
Several investigators, including ourselves, have reported significant changes in various immune responses in children with autism. These changes demonstrate dysregulation of the immune system (deficiency in some components of the immune system and excesses in others). In addition, certain genes in the major histocompatibility complex (that regulates immune responses) appear to be involved in autism. Based upon immunological abnormalities, various treatment modalities have been applied to children with autism. In this brief review, these immunological changes and various biological therapies are analyzed and summarized.
Unable to display preview. Download preview PDF.
- Fiers, W., & Buurman, W. A. (Eds). (1993). Tumor necrosis factor: Molecular and Cellular Biology and Clinical Relevance. Basel, Switzerland: Karger.Google Scholar
- Gupta, S. (1998). Intravenous immunoglobulin therapy in neurological disorders. Western Journal of Medicine, 167, 349–350.Google Scholar
- Gupta, S., Lee, T., & Aggarwal, S. (1998). Alterations in Th1 and Th2 subsets of CD4??and CD8??T cells in autism. Journal of Neuroimmunology, 14, 499–504.Google Scholar
- Hawkins, E. S., & Ribeiro, H. A. (1987). Pentoxifylline review. Journal of American Podiatric Medical Association, 77, 645–647.Google Scholar
- Kitatani, T., Watanabe, T., & Shibuya, T. (1993). Different effects of methyxanthines on central serotonergic postsynaptic neurons in a mouse behavioral model. Pharmacology Biochemical Behavior, 44, 457–461.Google Scholar
- Menage, P., Thibault, G., Barthelemy, C., Lelford, G., & Bardos, P. (1992). CD4??CD45RA??T lymphocyte deficiency in autistic children: Effect of a pyridoxin-magnesium treatment. Brain Dysfunction, 5, 326–333.Google Scholar
- Mintz, M., Rapaport, R., Oleske, J. M., Connor, E. A., Koenigsberger, M. R., & Denny, T. (1989). Elevated serum levels of tumor necrosis factor are associated with progressive encephalopathy in children with acquired immunodeficiency syndrome. American Journal of Diseases of Children, 143, 771–774.PubMedGoogle Scholar
- Mountz, J. M., Tolbert, L. C., Lill, D. W., Katholic, C. R., & Liu, H. G. (1995). Functional deficits in autistic disorder: Characterization by technetium-99m-HMPAO and SPECT. Journal of Nuclear Medicine, 38, 1156–1162.Google Scholar
- Rumsey, J. M., & Ernst, M. (in press). Functional neuroimaging of autistic disorders. Invited review. Mental Retardation and Developmental Disabilities Research Reviews. Google Scholar
- Schandene, L., Vandenbussche, P., Crusiaux, A., Alegre, M. L., Abramowicz, D., DuPont, E., Content, J., & Goldman, M. (1992). Differential effects of pentoxifylline on the production of tumor necrosis factor-alpha (TNF-?) and interleukin-6 (IL-6) by monocytes and T cells. Immunology, 76, 30–34.PubMedGoogle Scholar
- Singh, V. K., Warren, R. P., Odell, J. D., Cole, P., & Warren, L. (1993). Antibodies to myelin basic protein in children with autistic behavior. Brain, Behavior and Immnity, 7, 97–103.Google Scholar
- Wakefield, A. J., Murch, S. H., Anthony, A., Linnell, J., Casson, D. M., Malik, M., Berelowitz, M., Dhillon, A. P., Thomson, M. A., Harvey, P., Valentine, A., Davies, S. E., & Walker-Smith, J. A. (1998). Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet, 351, 637–641.PubMedGoogle Scholar
- Yonk, L. J., Warren, R. P., Burger, R. A., Cole, P., Odell, J. D., Warren, W. L., White, E., & Singh, V. K. (1990). CD4??helper T cell depletion in autism. Immunology Letters, 25, 344–346.Google Scholar